{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:16:56Z","timestamp":1783124216481,"version":"3.54.6"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82525060"],"award-info":[{"award-number":["82525060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biosafety and Health"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bsheal.2026.05.004","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:37:20Z","timestamp":1778765840000},"page":"208-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Research hotspots and trend analyses of maximum biosafety level pathogens: A bibliometric study using China\u2019s 2023 catalogue of pathogens as an example"],"prefix":"10.1016","volume":"8","author":[{"given":"Jing","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeerzhati","family":"Tuluhongtayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3605-4070","authenticated-orcid":false,"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bsheal.2026.05.004_b0005","first-page":"1507","article-title":"Basic, Translational State of the Science Working Group of the National Emerging Special Pathogens, Education Center\u2019s Special Pathogens Research, Preparedness and response considerations for high-consequence infectious disease","volume":"31","author":"Chan","year":"2025","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.bsheal.2026.05.004_b0010","series-title":"Laboratory Biosafety Manual","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.bsheal.2026.05.004_b0015","unstructured":"U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, and National Institutes of Health. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th ed., U.S. Government Printing Office, Atlanta, 2020."},{"key":"10.1016\/j.bsheal.2026.05.004_b0020","series-title":"Innovative Technologies for Advancement of WHO Risk Group 4 Pathogens Research, Global Virology III: Virology in the 21st Century","first-page":"437","author":"Logue","year":"2019"},{"key":"10.1016\/j.bsheal.2026.05.004_b0025","unstructured":"Chinese National Health Commission, People\u2019s Republic of China, Catalogue of pathogenic microorganisms transmitted to human beings. https:\/\/www.nhc.gov.cn\/qjjys\/c100016\/202308\/57f94fa7e121475ab87ff0ea14a92f6c.shtml, 2023 (accessed 13 February 2025)."},{"key":"10.1016\/j.bsheal.2026.05.004_b0030","unstructured":"Australia Group, List of human and animal pathogens and toxins for export control. https:\/\/www.dfat.gov.au\/publications\/minisite\/theaustraliagroupnet\/site\/en\/human_animal_pathogens.html, 2023 (accessed 25 February 2026)."},{"issue":"2","key":"10.1016\/j.bsheal.2026.05.004_b0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bsheal.2019.10.003","article-title":"Laboratory biosafety in China: Past, present, and future","volume":"1","author":"Wu","year":"2019","journal-title":"Biosaf. Health"},{"key":"10.1016\/j.bsheal.2026.05.004_b0040","unstructured":"King\u2019s College London. Global bioLabs report 2023. https:\/\/www.globalbiolabs.org\/., 2023 (accessed 13 February 2025)."},{"key":"10.1016\/j.bsheal.2026.05.004_b0045","first-page":"1","article-title":"Mapping biosafety level 3 (BSL-3) and BSL-4 laboratories for public health threats reduction","author":"Muluneh","year":"2025","journal-title":"J. Public Health (Oxf)"},{"issue":"2","key":"10.1016\/j.bsheal.2026.05.004_b0050","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4103\/1008-682X.171582","article-title":"Bibliometrics: Tracking research impact by selecting the appropriate metrics","volume":"18","author":"Agarwal","year":"2016","journal-title":"Asian J. Androl."},{"issue":"3","key":"10.1016\/j.bsheal.2026.05.004_b0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/S40037-021-00695-4","article-title":"Bibliometrics: Methods for studying academic publishing","volume":"11","author":"Ninkov","year":"2022","journal-title":"Perspect. Med. Educ."},{"issue":"2","key":"10.1016\/j.bsheal.2026.05.004_b0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.joi.2018.03.005","article-title":"Examining the usage, citation, and diffusion patterns of bibliometric mapping software: A comparative study of three tools","volume":"12","author":"Pan","year":"2018","journal-title":"J. Informetr."},{"issue":"1","key":"10.1016\/j.bsheal.2026.05.004_b0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bsheal.2024.12.001","article-title":"Bibliometric analysis of flavivirus-host interactions and immune responses: Research hotspots and trends","volume":"7","author":"Xiong","year":"2025","journal-title":"Biosaf. Health"},{"issue":"1","key":"10.1016\/j.bsheal.2026.05.004_b0070","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2530288","article-title":"Global research hotspots and trends in DNA vaccine research: A bibliometric and visualization study from 2014 to 2024","volume":"21","author":"Zhang","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.bsheal.2026.05.004_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104979","article-title":"Thirty years of research on negative symptoms of schizophrenia: A scientometric analysis of hotspots, bursts, and research trends","volume":"144","author":"Sabe","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.bsheal.2026.05.004_b0080","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10660-020-09410-7","article-title":"Knowledge mapping of platform research: A visual analysis using VOSviewer and CiteSpace","volume":"22","author":"Ding","year":"2020","journal-title":"Electron. Commer. Res."},{"key":"10.1016\/j.bsheal.2026.05.004_b0085","unstructured":"U.S. Department of Health and Human Services (HHS) & U.S. Department of Agriculture (USDA), HHS and USDA select agents and toxins. https:\/\/www.selectagents.gov\/sat\/list.htm, 2023 (accessed 25 February 2026)."},{"issue":"5319","key":"10.1016\/j.bsheal.2026.05.004_b0090","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/233434a0","article-title":"Bradford's Law","volume":"233","author":"Weinstock","year":"1971","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bsheal.2026.05.004_b0095","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.bsheal.2026.05.004_b0100","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s13238-016-0305-2","article-title":"On the ground in Western Africa: From the outbreak to the elapse of Ebola","volume":"7","author":"Liu","year":"2016","journal-title":"Protein Cell"},{"issue":"7","key":"10.1016\/j.bsheal.2026.05.004_b0105","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s11427-019-1670-6","article-title":"It's not just science: Challenges for public health intervention in Ebola epidemics in the Democratic Republic of Congo","volume":"63","author":"Wang","year":"2020","journal-title":"Sci. China Life. Sci."},{"issue":"1","key":"10.1016\/j.bsheal.2026.05.004_b0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-020-0147-3","article-title":"Ebola virus disease","volume":"6","author":"Jacob","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.bsheal.2026.05.004_b0115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/v11030274","article-title":"Ebola virus entry: from molecular characterization to drug discovery","volume":"11","author":"Salata","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.bsheal.2026.05.004_b0120","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-052016-100506","article-title":"The pathogenesis of Ebola virus disease","volume":"12","author":"Baseler","year":"2017","journal-title":"Annu. Rev. Pathol."},{"issue":"6","key":"10.1016\/j.bsheal.2026.05.004_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005665","article-title":"South african ebola diagnostic response in sierra leone: A modular high biosafety field laboratory","volume":"11","author":"Paweska","year":"2017","journal-title":"PLoS. Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.bsheal.2026.05.004_b0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40249-016-0154-5","article-title":"Good laboratory practices guarantee biosafety in the Sierra Leone-China friendship biosafety laboratory","volume":"5","author":"Wang","year":"2016","journal-title":"Infect. Dis. Poverty."},{"issue":"1","key":"10.1016\/j.bsheal.2026.05.004_b0135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12916-021-02028-y","article-title":"The East African Community (EAC) mobile laboratory networks in Kenya, Burundi, Tanzania, Rwanda, Uganda, and South Sudan-from project implementation to outbreak response against Dengue, Ebola, COVID-19, and epidemic-prone diseases","volume":"19","author":"Affara","year":"2021","journal-title":"BMC Med."},{"issue":"50","key":"10.1016\/j.bsheal.2026.05.004_b0140","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000040791","article-title":"Laboratory biosafety: A visual analysis in the web of science database from 2000 to 2022: A review","volume":"103","author":"Qi","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.bsheal.2026.05.004_b0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12985-021-01652-7","article-title":"A new Hendra virus genotype found in Australian flying foxes","volume":"18","author":"Wang","year":"2021","journal-title":"Virol. J."},{"issue":"3","key":"10.1016\/j.bsheal.2026.05.004_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008412","article-title":"Acute experimental infection of bats and ferrets with Hendra virus: Insights into the early host response of the reservoir host and susceptible model species","volume":"16","author":"Woon","year":"2020","journal-title":"PLoS. Pathog."},{"issue":"12","key":"10.1016\/j.bsheal.2026.05.004_b0155","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1751-0813.1998.tb12335.x","article-title":"Transmission studies of Hendra virus (equine morbillivirus) in fruit bats, horses and cats","volume":"76","author":"Williamson","year":"1998","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.bsheal.2026.05.004_b0160","article-title":"Safety precautions and operating procedures in an (A)BSL-4 laboratory: 3. aerobiology","volume":"116","author":"Bohannon","year":"2016","journal-title":"J. Vis. Exp."},{"issue":"2","key":"10.1016\/j.bsheal.2026.05.004_b0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/2049-632X.12171","article-title":"The NIAID integrated research facility at Frederick, Maryland: A unique international resource to facilitate medical countermeasure development for BSL-4 pathogens","volume":"71","author":"Jahrling","year":"2014","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.bsheal.2026.05.004_b0170","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-981-10-8727-1_21","article-title":"Countering zika virus: The USAMRIID response","volume":"1062","author":"Lowen","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.bsheal.2026.05.004_b0175","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/asi.20317","article-title":"CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature","volume":"57","author":"Chen","year":"2005","journal-title":"J. Am. Soc. Inf. Sci. Technol."},{"issue":"1","key":"10.1016\/j.bsheal.2026.05.004_b0180","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2544735","article-title":"Experimental challenge of African green monkeys with contemporary Hendra virus isolates produces divergent clinical disease","volume":"14","author":"Pigeaud","year":"2025","journal-title":"Emerg. Microbes Infect."},{"issue":"23","key":"10.1016\/j.bsheal.2026.05.004_b0185","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.1128\/JVI.75.23.11677-11685.2001","article-title":"Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses","volume":"75","author":"Pushko","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.bsheal.2026.05.004_b0190","doi-asserted-by":"crossref","unstructured":"P.B. Jahrling, J.D. Frame, S.B. Smith, M.H. Monson, Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates, Trans. R. Soc. Trop. Med. Hyg. 79 (3) (1985) 374-9, https:\/\/doi.org\/10.1016\/0035-9203(85)90386-4.","DOI":"10.1016\/0035-9203(85)90386-4"},{"issue":"1","key":"10.1016\/j.bsheal.2026.05.004_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1890370102","article-title":"Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys","volume":"37","author":"McCormick","year":"1992","journal-title":"J. Med. Virol."},{"issue":"12","key":"10.1016\/j.bsheal.2026.05.004_b0200","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/jcm.28.12.2689-2692.1990","article-title":"Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction","volume":"28","author":"Lunkenheimer","year":"1990","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.bsheal.2026.05.004_b0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/jinf.2000.0782","article-title":"The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia","volume":"42","author":"Chua","year":"2001","journal-title":"J. Infect."},{"issue":"8","key":"10.1016\/j.bsheal.2026.05.004_b0210","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/infdis\/jit004","article-title":"A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques","volume":"207","author":"Safronetz","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"105","key":"10.1016\/j.bsheal.2026.05.004_b0215","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002901","article-title":"A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge","volume":"3","author":"Bossart","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.bsheal.2026.05.004_b0220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/1389450114888131204163210","article-title":"The RNA-dependent-RNA polymerase, an emerging antiviral drug target for the Hendra virus","volume":"15","author":"Velkov","year":"2014","journal-title":"Curr Drug Targets"},{"issue":"6233","key":"10.1016\/j.bsheal.2026.05.004_b0225","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1126\/science.aaa4919","article-title":"Vaccines An ebola whole-virus vaccine is protective in nonhuman primates","volume":"348","author":"Marzi","year":"2015","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bsheal.2026.05.004_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003736","article-title":"A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses","volume":"9","author":"Safronetz","year":"2015","journal-title":"PLoS. Negl. Trop Dis"},{"key":"10.1016\/j.bsheal.2026.05.004_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1216225","article-title":"Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease","volume":"14","author":"Monath","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bsheal.2026.05.004_b0240","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.omtm.2022.08.003","article-title":"AAV-monoclonal antibody expression protects mice from Ebola virus without impeding the endogenous antibody response to heterologous challenge","volume":"26","author":"van Lieshout","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"6","key":"10.1016\/j.bsheal.2026.05.004_b0245","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/v10060286","article-title":"Post-exposure protection in mice against sudan virus by a two antibody cocktail","volume":"10","author":"Froude","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.bsheal.2026.05.004_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.703986","article-title":"Recombinant protein filovirus vaccines protect cynomolgus macaques from ebola, sudan, and marburg viruses","volume":"12","author":"Lehrer","year":"2021","journal-title":"Front. Immunol."},{"issue":"1932","key":"10.1016\/j.bsheal.2026.05.004_b0255","article-title":"Emerging infectious disease and the challenges of social distancing in human and non-human animals","volume":"287","author":"Townsend","year":"2020","journal-title":"Proc. Biol. Sci."},{"issue":"8","key":"10.1016\/j.bsheal.2026.05.004_b0260","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s11427-021-2071-x","article-title":"Surveillance of emerging infectious diseases for biosecurity","volume":"65","author":"Hao","year":"2022","journal-title":"Sci. China Life Sci."},{"issue":"10","key":"10.1016\/j.bsheal.2026.05.004_b0265","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1080\/21645515.2019.1634992","article-title":"Emerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development","volume":"15","author":"Roberts","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"issue":"7552","key":"10.1016\/j.bsheal.2026.05.004_b0270","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature14442","article-title":"Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates","volume":"521","author":"Thi","year":"2015","journal-title":"Nature"}],"container-title":["Biosafety and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590053626000789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590053626000789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:27:58Z","timestamp":1783121278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590053626000789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2590053626000789"],"URL":"https:\/\/doi.org\/10.1016\/j.bsheal.2026.05.004","relation":{},"ISSN":["2590-0536"],"issn-type":[{"value":"2590-0536","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research hotspots and trend analyses of maximum biosafety level pathogens: A bibliometric study using China\u2019s 2023 catalogue of pathogens as an example","name":"articletitle","label":"Article Title"},{"value":"Biosafety and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bsheal.2026.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Chinese Medical Association Publishing House Co. Ltd. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}